Letters to the EditorPitfalls in Reporting Sample Size Calculation Across Randomized Controlled Trials Involving Ivermectin for the treatment of COVID-19Kow, Chia Siang MPharm1,2; Hasan, Syed S. PhD3,4 Author Information 1School of Pharmacy, Monash University Malaysia Bandar Sunway, Selangor, Malaysia 2School of Postgraduate Studies, International Medical University, Kuala Lumpur, Malaysia 3School of Applied Sciences, University of Huddersfield, Huddersfield, United Kingdom 4School of Biomedical Sciences and Pharmacy University of Newcastle, Callaghan, Australia The authors have no conflicts of interest to declare. All authors contributed equally in the manuscript development. C. S. Kow wrote the first draft of the manuscript. S. S. Hasan revised the first draft of the manuscript and designed the tables. American Journal of Therapeutics: September/October 2021 - Volume 28 - Issue 5 - p e616-e619 doi: 10.1097/MJT.0000000000001441 Buy Metrics Copyright © 2021 Wolters Kluwer Health, Inc. All rights reserved.